Regulations.gov document
Guidance for Industry on Postmarketing Studies and Clinical Trials; Availability…
Notice · FDA-2009-D-0283 · posted Apr 1, 2011
Key facts
| Document ID | FDA-2009-D-0283-0020 |
|---|---|
| Title | Guidance for Industry on Postmarketing Studies and Clinical Trials; Availability: Implementation of Section 505(o)(3) of the Federal Food, Drug, and Cosmetic Act |
| Document type | Notice |
| Subtype | NAD-Notice of Availability of Data |
| Agency | FDA |
| Docket | FDA-2009-D-0283 |
| Posted | Apr 1, 2011 |
| Federal Register citation | 76 FR 18226 |
| FR document number | 2011-07707 |
| Comment period opens | Apr 1, 2011 |
| Effective date | Apr 1, 2011 |
At a glance
- 1–9 Pages
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: